- Open Access
Structural chromosome aberrations cause swelling of the nucleus
© The Author(s) 2016
- Received: 13 November 2015
- Accepted: 27 May 2016
- Published: 1 October 2016
Carcinogens are known to cause swelling of the mammalian cell nucleus. However, the mechanism of the swelling and its toxicological significance have not been fully elucidated. Since nuclear swelling (NS hereafter) has been frequently observed in chromosomal aberration (CA hereafter) tests (in vitro), the relationship between NS and CAs was investigated in this study.
In a short-term CA test using the fibroblast CHL cell line, the appearance of NS increased in a dose-dependent manner after exposure to six types of clastogens (mitomycin C, methyl methane sulfonate, 1-methyl-3-nitro-1-nitrosoguanidine, benzo[a]pyrene, cyclophosphamide monohydrate, and 9,10-dimethyl-2-benzanthracene), and a strong correlation was found between NS (%) and CAs (%) at each dosage. Therefore, we hypothesized that clastogens cause NS in cultured mammalian cells, since the mouse lymphoma L5178Y cell line is known to have a similar sensitivity to clastogens. Thus, we measured NS for 14 compounds (clastogens) that are known to induce structural CAs, 4 aneugens, and 12 non-mutagenes. Almost all clastogens caused NS of more than 5 %, which increased in a dose-dependent manner. Among the aneugens, colchicine, and diethylstilbestrol caused the same level of NS % as the clastogens, while carbendazim and trichlorfon caused a similar level of NS % as the clastogens only at higher levels of cytotoxicity. Almost all the non-mutagens caused less than 5 % NS.
These results strongly suggest that NS is mainly caused by structural aberrations in the nucleus during interphase of the cell cycle.
- Chromosomal aberration
- Nuclear swelling
Carcinogens cause swelling of the mammalian cell nucleus, a phenomenon first reported by Page . Numerous studies have evaluated nuclear swelling (NS), including in cultured mammalian cells (e.g., HeLa S3 cells) by Agrelo . Grant and Finch et al. proposed a screening test (nuclear enlargement assay) for identifying carcinogens based on NS [3, 4]. However, as described by Westmoreland et al., because most instances of NS are independent of abnormal enhancement of DNA synthesis , the mechanism of NS differs from those occurring in cellular senescence and cancerous cells [6, 7]. The mechanisms of NS and its toxicological significance remain unclear. Most carcinogens that cause NS are genotoxins, which cause DNA damage, chromosomal aberrations (CAs), and micronucleus formation. Because NS is often observed during the mammalian CA test (in vitro), we examined the relationship between NS and CAs. If NS is related to genotoxicity, it may be useful to measure NS in various cultured mammalian cell lines; we obtained additional information nearly simultaneously through additional microgram-scale sampling during the respective cell assays.
In this study, the correlation between NS and CAs was examined using CA tests for clastogens in the Chinese hamster lung CHL/IU cell line. NS measurements were carried out using compounds known to induce structural CAs in the mouse lymphoma L5178Y cell line. L5178Y is often used in mouse lymphoma L5178Y cell Tk (thymidine kinase) gene mutation assays. These assays can detect mutations in the Tk gene that result from both gene mutations and chromosome damage. It has also been reported that MMS, MNNG, 2AF, B (a) P, and DMBA cause chromosomal aberrations in L5178Y [8–11], and thus we hypothesized that L5178Y has a similar sensitivity to clastogens as the CHL [12, 13].
The CHL cell line was obtained from the Health Science Research Resources Bank (HSRRB, Osaka, Japan). The CHL cells were cultured in Eagle’s MEM supplemented with 10 % (v/v) heat-inactivated calf serum. Mouse lymphoma L5178Y TK+/−3.7.2c cells (L5178Y hereafter) were donated by the National Institute of Health Sciences (Tokyo, Japan). The L5178Y cells were cultured in RPMI1640 supplemented with 10 % (v/v) heat-inactivated horse serum and sodium pyruvate (200 μg/ml) in a humidified incubator at 37 °C with 5 % CO2.
List of compounds tested
Compound (Another name)
Mitomycine C (MMC)
Methyl methane sulfonate (MMS)
Cyclophosphamide Monohydrate (CP)
4-Nitroquinoline 1-Oxide (4NQO)
1-Methyl-5H-pyrido[4,3-b]indole-3-amine・acetic acid (Trp-P-2 Acetate)1-Methyl-5H-pyrido[4,3-b]indole-3-amine・acetic acid (Trp-P-2 Acetate)
Methyl 2-benzimidazole carbamate (Carbendazim)
2,2,2-Trichloro-1-hydroxyethyl dimethyl phosphate (Trichlorfon)
L(+)-Ascorbic acid (Vitamin C)
dl-a-Tocopherol (Vitamin E)
Metabolic activation system
To determine the influence of metabolic activation for a test compound, S9 mix was used. The S9 fraction was prepared from male Sprague–Dawley rats that were pretreated with the enzyme-inducing agents phenobarbital and 5, 6-benzoflabone, which were obtained from the Oriental Yeast Co. Ltd (Tokyo, Japan). In the experiment, S9 mix was added so that the S9 fraction concentrations were 5 % (v/v) for CHL and 2 % (v/v) for L5178Y cells in the final test medium. The S9 mix for CHL cells was prepared as follows: 2 ml of S9, 1.34 ml of 20 mM HEPES, 0.67 ml of 50 mM MgCl2, 0.67 ml of 330 mM KCl, 0.67 ml of 50 mM glucose-6-phosphate, 0.67 mM of 40 mM NADP(Na2), and 0.67 ml of purified water. The S9 mix for L5178Y cells was prepared as follows: 2 ml of S9, 1 ml of 0.18 g/ml glucose-6-phosphate, 1 ml of 25 mg/ml NADP, and 1 ml of 150 ml KCl.
Treatment for CHL cells
Five milliliters of culture medium (4000 cells/ml) was added to a plastic Petri dish (60-mm diameter). After a 3-day incubation, the cells were exposed to the test compounds for 6 h. When appropriate, S9 mix (for metabolic activation) was also added to the medium. Furthermore, an 18-h recovery time was needed, and 2 h before cell sample collection, colcemid was added to the medium at a final concentration of 0.2 μg/ml in order to harvest the cells in the metaphase state. Trypsin was used to separate the cells from the Petri dishes, and the obtained cells were used to measure or estimate NS and CAs.
Treatment for L5178Y cells
Cells (400 μl at a density of 5 × 105 cells/ml) in the exponential cell growth phase were cultured in 1.5 ml micro-tubes, and the prescribed amounts of the test compounds were added, followed by the proper amount of 150 mM KCl (without metabolic activation) or S9 mix (with metabolic activation). After shaking gently at 37 °C in an incubator for 3 h, the cells were collected using centrifugation, and the supernatant was removed. One milliliter of fresh medium was added to the micro-tube, and the mixture was transferred to a 24-well plate. After a 21-h incubation, NS was measured and analyzed.
Analyses of CAs
Cells were suspended and incubated in a 0.075 M KCl hypotonic solution for 15 min at 37 °C, and they were then fixed in ice-cold Carnoy solution (1:3 = acetic acid: ethanol). The fixed cell suspension was dropped on a glass slide, air-dried, and stained with Giemsa solution. A total of 100 cell images in metaphase were observed per dose with a microscope (Olympus BX50) at 600× magnification. When the number of metaphase cells was less than 100 because of cytotoxicity, all metaphase cells were counted per dose.
Measurements of NS
Cell suspensions were fixed by adding formalin to a final concentration of 2 % (v/v), and the suspensions were then fluorescent stained by adding 50 μg/ml DAPI or 50 μg/ml Hoechst 33342 at a final concentration of 1 to 2 % (v/v) of the suspension. For CHL cells, the cell density was concentrated to 2 to 4 times, and the concentrated cell suspensions were placed between two glass plates with a 0.07-mm space using Sekisui microscopy plates (UR-137-S) obtained from Sekisui Chemical Co., Ltd. A total of 72 pictures (frames) of the cells per dose were taken with a fluorescence microscope (Olympus BX50FLA equipped with a 20× objective lens and a Nippon Roper chromosome inspection supporting system CIS-02) at a frame size of 646 μm × 483 μm. This was equivalent to taking pictures of 1.57 μl of the cell suspension. The resulting image data were analyzed using Image-Pro Plus image analysis software (ver. 5), and the number of cell nuclei was counted, and their area was measured. Using standard measures of nuclear size, NS was discriminated from other conditions.
The following formula for cytotoxicity assessment was used:
Fisher’s exact tests and Chi-squared tests were used to determine whether there were statistical differences between the negative control group and the treated group in the appearance of NS. For clastogen tests using CHL cells, the correlation coefficient (r2) was calculated to evaluate the correlation between NS (%) and CA (%) at each concentration. The significance level was set at p < 0.05 for all statistical analyses.
CAs and NS for CHL cells
NS of L5178Y cells
In the CHL cell tests using six types of clastogens, each compound showed a high correlation between CAs (%) and NS (%). Therefore, NS (%), which does not depend on the abnormal enhancement of DNA synthesis, was due to the structural CAs in the interphase state. Normal individual chromosomes in interphase cell nuclei have a highly discrete compartment called chromosome territories . Chromosomes damaged by radiation move into these chromosome territories . Since clastogens also damage the structure of chromosomes, consequently, the chromosome territories might be distorted or destroyed. As a result, differences in the strain and stress of chromosome positioning will cause NS in interphase. Some of the differences between NS (%) and CAs (%) may be due to other factors contributing to NS. Since there are various mechanisms for chromosome repair functions, the different characteristics of chemicals might affect the degree of NS (%).
If NS reflects structural CAs, then a larger number of chromosomes in a cell may lead to a greater degree of NS, provided that each chromosome has same basic volume irrespective of the cell nuclear species. For example, the number of chromosomes in CHL cells is 25, while the number in L5178Y cells is 40, and thus the degree of NS in L5178Y cells is expected to be greater than that in CHL cells. However, the experimental results of swelling showed that both cells had similar cross-sections of approximately 30 μm2, i.e., both cells showed nearly the same volumetric increase. These results do not support our hypothesis. However, the results suggest that a certain amount of space is required to repair structural chromosome aberrations in the nucleus.
In the L5178Y cell tests, the appearance of NS (%) increased in a dose-dependent manner for almost clastogens tested. However, MNNG and 2-acetamidofluorene showed bell-shaped dose–response curves, and it was concluded that the cytotoxicity of these compounds was a more important factor than NS at high doses. In other words, the appearance of NS is due to factors other than cell death.
AF2 is a typical positive control. On the other hand, one study reported that diphenylamine caused micronuclei formation in human lymphocytes , and it is considered a weak clastogen . These compounds caused similar degrees of NS (%).
Colchicine causes NS, and it also causes structural and numerical CAs . Thus, these characteristics are consistent with our experimental results in that colchicine caused higher NS (%) values than the other aneugens. DES with metabolic activation caused NS (%) at more than 5 % relative frequency. There are reports that DES causes sister-chromatid exchanges and structural CAs in vitro in rodent cell lines [29, 30], and it is expected that DES will also cause NS. NS (%) values following exposure to non-mutagens were greater than 5 % at dosages of 500 μg/ml (+S9) for toluene, 7.8 μg/ml (+S9) for β-carotene, and 2.0 μg/ml (+S9) for cyclohexene. NS (%) caused by toluene at high cytotoxicity levels is due to the same phenomenon that caused CAs at high cytotoxicity levels. The non-mutagens tested did not produce clearly defined NS (%) in the present study. These results strongly suggest that NS associated with genotoxicity is caused by structural aberrations in the nucleus during interphase of the cell cycle.
NS during interphase (S, G2) is different from CAs that occur during the mitotic phase, as the cell has passed the G2/M checkpoint, but NS can be used to detect the effect of clastogens. The NS assay is a new method for assessing genotoxicity. This assay can also be applied in conjunction with other tests because it requires an extremely small amount of sample, and the assay can be automated to reduce the amount of time required.
In a short-term CA test using the fibroblast CHL cell line, the appearance of NS (%) increased in a dose-dependent manner after exposure to six types of clastogens (MMC, MMS, MNNG, BP, CP, and DMBA), and a strong correlation was found between NS (%) and CAs (%) at each dosage. Therefore, we hypothesized that clastogens cause NS in cultured mammalian cells, since the mouse lymphoma L5178Y cell line is known to have a similar sensitivity to clastogens. Thus, we measured NS (%) for 14 compounds (clastogens) that are known to induce structural CAs, 4 aneugens, and 12 non-mutagenes. Almost all clastogens caused NS (%) of more than 5 %, which increased in a dose-dependent manner. Among the aneugens, colchicine, and diethylstilbestrol caused the same level of NS (%) as the clastogens, while carbendazim and trichlorfon caused a similar level of NS (%) as the clastogens only at higher levels of cytotoxicity. Almost all the non-mutagens caused less than 5 % NS. These results strongly suggest that NS is mainly caused by structural aberrations in the nucleus during interphase of the cell cycle.
We would like to thank Dr. Tetsutaro Yoshinaga (former professor at Kyushu Kyoritsu University) and Dr. Masamitsu Honma (Chief, Division of Genetics & Mutagenesis, National Institute of Health Sciences) for their scientific advice and encouragement. We would also like to thank UBE Scientific Analysis Laboratory, Inc. for the financial support.
KT made substantial contributions to the conception and design of the study, acquisition of the data, and analysis and interpretation of the data. HIO and TM were involved in drafting the manuscript and revising it critically for important intellectual content. TM has given final approval of the version to be published. All authors read and approved the final manuscript.
The authors declare that they have no competing interest.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Page RC. Cytologic changes in the skin of mice during application of carcinogenic agents. Arch Pathol. 1938;26:800–13.Google Scholar
- Agrelo CE. The effect of carcinogens on the nuclear size of Hela cells. Toxicology. 1978;9:21–7.View ArticlePubMedGoogle Scholar
- Grant D, Grasso P. Suppression of Hela cell growth and increase in nuclear size by chemical carcinogens: a possible screening method. Mutation Res. 1978;57:369–80.View ArticlePubMedGoogle Scholar
- Finch RA, Evans IM, Bosmann HB. Chemical carcinogen in vitro testing: a method for sizing cell nuclei in the nuclear enlargement assay. Toxicology. 1980;15:145–54.View ArticlePubMedGoogle Scholar
- Westmoreland C, Benford DJ, Eales LJ, Grasso P. Investigations into the mechanisms of carcinogen-induced nuclear enlargement in Hela S3 cells in vitro. Toxic In Vitro. 1994;8(5):1139–50.View ArticleGoogle Scholar
- Kobayashi Y, Sakemura R, Kumagai A, Sumikawa E, Fujii M, Ayusawa D. Nuclear swelling occurs during premature senescence mediated by MAP kinases in normal human fibroblasts. Biosci Biotechnol Biochem. 2008;72(4):1122–5.View ArticlePubMedGoogle Scholar
- Johmura Y, Shimada M, Misaki T, Naiki-Ito A, Miyoshi H, Motoyama N, Ohtani N, Hara E, Nakamura M, Morita A, Takahashi S, Nakanishi M. Necessary and sufficient role for a mitosis skip in senescence induction. Mol Cell. 2014;55:1–12.View ArticleGoogle Scholar
- Moore MM, Clive D, Hozier JC, Howard BE, Batson AG, Turner NT, Sawyer J. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells. Mutation Res. 1985;151:161–74.View ArticlePubMedGoogle Scholar
- Hozier J, Sawyer J, Clive D, Moor MM. Chromosome 11 aberrations in small colony L5178Y TK−/− mutants early in their clonal history. Mutation Res. 1985;147:237–42.View ArticlePubMedGoogle Scholar
- Doerr CL, Harrington-Brock K, Moore MM. Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells. Mutation Res. 1989;222:191–203.View ArticlePubMedGoogle Scholar
- Honma M, Hayashi M, Shimada H, Tanaka N, Wakuri S, Awogi T, Yamamoto KI, Kodani N, Nishi Y, Nakadate M, Sofuni T. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis. 1999;14(1):5–22.View ArticlePubMedGoogle Scholar
- Lorge E, Thybaud V, Aardema MJ, Oliver J, Wakata A, Lorenzon G, Marzin D. SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study. Mutation Res. 2006;607:13–36.View ArticlePubMedGoogle Scholar
- ICH harmonised tripartite guideline, Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use S2(R1), Current Step 4 version dated 9 November 2011 (2.1 Rationale)Google Scholar
- Ishidate Jr M. Data Book of Chromosomal Aberration Test in Vitro (in Japanese). Tokyo: L.I.C. Inc.; 1987.Google Scholar
- Sofuni T, editor. Revised Edition 1998, Data Book of Chromosomal Aberration Test in Vitro (in Japanese). Tokyo: L.I.C. Inc.; 1999.Google Scholar
- The MUTANTS: Database of Genotoxcity of Chemicals, http://members3.jcom.home.ne.jp/mo-ishidate/index.html. Accessed Nov 2015.
- Ministry of Health, Labour and Welfare, Workplace safety site, mutagenicity test (Ames, chromosomal abnormality) Result http://anzeninfo.mhlw.go.jp/user/anzen/kag/sokatutbl.htm. Accessed Nov 2015.
- Mitchell AD, Auletta AE, Clive D, Kirby PE, Moore MM, Myhr BC. The L5178Y/tk+/− mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Res. 1997;394:177–303.View ArticlePubMedGoogle Scholar
- Pharmaceutical interview form-Terumo (This document include the clastogenicity of acetaminophen in L5178Y.), http://www.terumo.co.jp/medical/drug/upload_files/acelio_if.pdf. Accessed Apr 2016.
- United States Environmental Protection Agency Pesticides: Reregistration, https://archive.epa.gov/pesticides/reregistration/web/html/status.html. Accessed Apr 2016.
- United States National Library of Medicine, Toxicology Data Network (TOXNET), Chemical Carcinogenesis Research Information System (CCRIS), Genetic Toxicology Data Bank (GENE-TOX), http://toxnet.nlm.nih.gov/newtoxnet/genetox.htm. Accessed Apr 2016.
- OECD (2014), In Vitro Mammalian Cell Micronucleus Test, Test Guideline No. 487, OECD Guidelines for Testing of ChemicalsGoogle Scholar
- OECD (2014), In Vitro Mammalian Chromosomal Aberration Test, Test Guideline No. 473, OECD Guidelines for Testing of ChemicalsGoogle Scholar
- Galloway S, Lorge E, Aardema MJ, Eastmond D, Fellows M, Heflich R, Kirkland D, Levy DD, Lynch AM, Marzin D, Morita T, Schuler M, Speit G. Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus). Mutation Res. 2011;723:77–83.View ArticlePubMedGoogle Scholar
- Tanabe H. Chromosome territory: recent advancement of studies on interphase chromosome positioning in relation to nuclear architecture. Environ Mutagen Res. 2003;25:11–22.View ArticleGoogle Scholar
- Gandhi M, Evdokimova VN, Cuenco KT, Bakkenist CJ, Nikiforov YE. Homologous chromosomes move and rapidly initiate contact at the sites of double-strand breaks in genes in G-phase human cells. Cell Cycle. 2013;12(4):547–52.View ArticlePubMedPubMed CentralGoogle Scholar
- Santovito A, Cervella P, Delpero M. Micronucleus frequency in human lymphocytes after exposure to diphenylamine in vitro. Mutation Res. 2012;747(1):135–7.View ArticlePubMedGoogle Scholar
- Arni P, Hertner T. Chromosomal aberrations in vitro induced by aneugens. Mutat Res. 1997;379:83–93.View ArticlePubMedGoogle Scholar
- Banduhn N, Obe G. Mutagenicity of methyl 2-benzimidazolecarbamate, diethylstilbestrol and estradiol structural aberrations, sister-chromatid exchanges, C-mitosis, polyploidies and micronuclei. Mutation Res. 1985;156(3):199–218.View ArticlePubMedGoogle Scholar
- Tayama S, Nakagawa Y, Tayama K. Genotoxic effects of environmental estrogen-like compounds in CHO-K1 cells. Mutat Res. 2008;649:114–25.View ArticlePubMedGoogle Scholar